| [1] |
Kumar JV, Doval DC, Rao R, et al. A retrospective study of patients with locally advanced cancer of the cervix treated with neoadjuvant chemotherapy followed by radical surgery[J]. Int J Gynecol Cancer, 2009, 19(3):417-422.
|
| [2] |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2):115-132.
|
| [3] |
郭晓霞, 田玉旺, 张立英, 等. 41751例女性宫颈细胞中HPV基因分型的回顾性分析[J]. 临床与病理杂志, 2016, 36(2):113-127.
|
| [4] |
Egawa N, Egawa K, Griffin H, et al. Human Papillomaviruses; Epithelial Tropisms, and the Development of Neoplasia[J]. Viruses, 2015, 7(7):3863-3890.
|
| [5] |
Gustinucci D, Giorgi Rossi P, Cesarini E, et al. Use of Cytology, E6/E7 mRNA, and p16INK4a-Ki-67 to Define the Management of Human Papillomavirus (HPV)-Positive Women in Cervical Cancer Screening[J]. Am J Clin Pathol, 2016, 145(1):35-45.
|
| [6] |
Groves IJ, Coleman N. Pathogenesis of human papillomavirus-associated mucosal disease[J]. J Pathol, 2015, 235(4):527-538.
|
| [7] |
范莹莹, 张健, 徐冰. Aptima HPV联合宫颈液基细胞学筛查宫颈癌前病变的临床研究[J]. 陕西医学杂志, 2017, 46(2):162-164.
|
| [8] |
蒋欣, 张亚军, 江月, 等. 高危HPV E6/E7mRNA与HPV DNA检测对宫颈病变诊断及风险评估的价值[J]. 广东医学, 2018, 39(增刊):132-135,139.
|
| [9] |
Li Y, Rong S, Zhi Y, et al. Detection of cervical intrae-pithelial neoplasia with HPV E6/E7 mRNA among women with atypical squamous cells of unknown significance[J]. Int J Gynaecol Obstet, 2017, 137(2):145-149.
|
| [10] |
曾冰微, 黄种心, 张东妹. 高危型HPV E6/E7mRNA在宫颈病变筛查中的价值探讨[J]. 中国妇产科临床杂志, 2018, 19(1):9-11.
|
| [11] |
Yao YL, Tian QF, Cheng B, et al. Human papillomavirus (HPV) E6/E7 mRNA detection in cervical exfoliated cells: a potential triage for HPV-positive women[J]. J Zhejiang Univ Sci B, 2017, 18(3):256-262.
|
| [12] |
Baron C, Henry M, Tamalet C, et al. Relationship between HPV 16, 18, 31, 33, 45 DNA detection and quantitation and E6/E7 mRNA detection among a series of cervical specimens with various degrees of histological lesions[J]. J Med Virol, 2015, 87(8):1389-1396.
|
| [13] |
李莉, 王林, 李志芳, 等. Aptima HPV E6/E7mRNA 技术检出宫颈癌及癌前病变的临床效果研究[J]. 中国妇产科临床杂志, 2018, 19(4):341-344.
|
| [14] |
王翠玲, 李开智, 崔文. HPV E6/E7mRNA 检测对宫颈 HSIL/SCC 的诊断价值[J]. 济宁医学院学报, 2018, 41(6):400-402,406.
|
| [15] |
陈文倩, 张晓童, 贾相奇, 等. HPV E6/E7mRNA 联合液基细胞学检查在宫颈癌筛查中的意义[J]. 滨州医学院学报, 2018, 41(5):359-361,364.
|
| [16] |
王彤, 黄仲禄, 谢海容, 等. HPV E6/E7mRNA联合TCT检查在宫颈癌早期筛查中的应用[J]. 中国妇幼保健, 2018, 33(18):4272-4275.
|
| [17] |
Ren C, Zhu Y, Yang L, et al. Diagnostic performance of HPV E6/E7 mRNA assay for detection of cervical high-grade intraepithelial neoplasia and cancer among women with ASCUS Papanicolaou smears[J]. Arch Gynecol Obstet, 2018, 297(2):425-432.
|
| [18] |
徐瑛, 高志斌, 黄丽丽, 等. 基于数学模型的高危HPV E6/E7mRNA定量分析在宫颈病变筛查中的作用[J]. 中国医学物理学杂志, 2017(1):76-79.
|
| [19] |
赵芬.人乳头瘤病毒E6/E7mRNA定量检测在宫颈病变筛查中的临床研究[D]. 浙江: 2016.
|
| [20] |
陈红舟, 查瑶, 周吉航, 等. 液基细胞学联合HPV DNA及E6/E7mRNA定量检测筛查宫颈病变的临床价值[J]. 浙江临床医学, 2015, 17(10):1799-1800.
|
| [21] |
任美英, 王翠峰, 菅建国, 等. TCT联合HPV E6/E7mRNA定量检测宫颈上皮内瘤变的临床应用价值[J]. 中国医学创新, 2016, 13(36):98-100,101.
|
| [22] |
班婷, 李建湘, 潘琦文. TCT与HPV E6/E7mRNA定量检测宫颈上皮内瘤变的价值分析[J]. 实用妇科内分泌杂志(电子版), 2017, 4(19):30-31.
|
| [23] |
蒙玉刚, 安明, 徐文生, 等. HR-HPV及TCT检查评价宫颈上皮内瘤变宫颈锥切术后残留、复发的意义[J]. 广西医学, 2013, 35(3):323-324.
|
| [24] |
桂定清, 张力忆, 青友芬, 等. HPV E6/E7mRNA检测对宫颈上皮内瘤变患者的预后价值[J]. 空军医学杂志, 2018, 34(6):408-411.
|
| [25] |
张飞芳, 叶丽燕. HPV E6/E7mRNA检测对宫颈锥切术后ASCUS患者分流诊断的价值[J]. 浙江医学, 2018, 40(7):680-683.
|
| [26] |
赵花, 邵华江. HPV E6/E7mRNA检测对宫颈锥切术后病灶残留和复发的诊断价值[J]. 中南大学学报:医学版, 2016, 41(6):606-611.
|
| [27] |
吴晶晶, 苏维娜, 林清清. 高危型人乳头瘤病毒E6/E7mRNA检测在宫颈锥切术后患者随访中的应用价值[J]. 现代实用医学, 2016, 28(9):1204-1206.
|
| [28] |
万志佳, 刘文果. HPV E6/E7mRNA检测对高级别宫颈鳞状上皮内瘤变患者锥切术后疾病持续/复发的诊断价值[J]. 国际检验医学杂志, 2018, A02:23-27.
|
| [29] |
Massimo O, Paolo C, Guia C, et al. Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities[J]. Ecancer, 2015, 9:533.
|
